C-Reactive Protein-Lymphocyte Ratio Identifies Patients at Low Risk for Major Morbidity after Oesophagogastric Resection for Cancer

Author:

Neary Colm,McAnena Peter,McAnena Oliver,Kerin Michael,Collins Chris

Abstract

<b><i>Introduction:</i></b> Complications following oesophagogastric surgery have significant implications for patient recovery. <b><i>Objective:</i></b> identify cost-effective biomarkers which can predict morbidity. <b><i>Methods:</i></b> Analysis of all upper gastrointestinal resections in Galway University Hospital from 2014 to 2018 was performed. The ability of C-reactive protein (CRP), neutrophil-lymphocyte ratio (NLR), and CRP-lymphocyte ratio (CLR) to predict morbidity, including anastomotic leak (AL), was assessed and compared. <b><i>Results:</i></b> Seventy-one oesophagectomies and 77 gastrectomies were performed. There were 2 (1%) 30-day mortalities and 83 (56%) morbidities of which 30 (20%) were of Clavien-Dindo grade 3 or higher. The rate of major morbidity within the oesophagectomy cohort was 27% and was 14% in the gastrectomy cohort. There were 11 (7%) ALs, 7 in the oesophagectomy cohort, and 4 in the gastrectomy cohort. From post-operative day (POD) 2 onwards, CRP could predict AL (POD2 AUC = 0.705, <i>p =</i> 0.025; POD3 AUC = 0.757, <i>p</i> = 0.005, POD4 AUC = 0.811, <i>p</i> = 0.001; and POD5 AUC = 0.824, <i>p</i> = 0.001). CLR predicted AL on POD2 onwards (POD2 AUC = 0.722, <i>p</i> = 0.005; POD3 AUC = 0.736, <i>p =</i> 0.01; POD4 AUC = 0.775, <i>p</i> = 0.003; and POD5 AUC = 0.817, <i>p</i> = 0.001). CRP level of 218 mg/dL and CLR level of 301 at POD 2 generated negative predictive values of 97 and 98%, respectively, for AL. Post-operative NLR did not display sufficient discriminatory ability for the outcomes. <b><i>Conclusion:</i></b> CRP and CLR are reliable negative predictors of major morbidity, including AL, after oesophagogastric resection. Their use can inform patient intervention and recovery.

Publisher

S. Karger AG

Subject

Gastroenterology,Surgery

Reference34 articles.

1. Li YJ, Huo TT, Xing J, An JZ, Han ZY, Liu XN, et al. Meta-analysis of efficacy and safety of fast-track surgery in gastrectomy for gastric cancer. World J Surg. 2014;38(12):3142–51.

2. Ljungqvist O, Scott M, Fearon KC. Enhanced recovery after surgery: a review. JAMA Surg. 2017;152(3):292–8.

3. Porteous GH, Neal JM, Slee A, Schmidt H, Low DE. A standardized anesthetic and surgical clinical pathway for esophageal resection: impact on length of stay and major outcomes. Reg Anesth Pain Med. 2015;40(2):139–49.

4. Boshier PR, Anderson O, Hanna GB. Transthoracic versus transhiatal esophagectomy for the treatment of esophagogastric cancer: a meta-analysis. Ann Surg. 2011;254(6):894–906.

5. Cheng Q, Pang TC, Hollands MJ, Richardson AJ, Pleass H, Johnston ES, et al. Systematic review and meta-analysis of laparoscopic versus open distal gastrectomy. J Gastrointest Surg. 2014;18(6):1087–99.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3